Springer Health+ IME

Springer Health+ IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.

[Springer Health+ IME @SpringerIME]

With #ADA2026 right around the corner, now’s the perfect time to familiarize yourself with the latest in ketone monitoring with our free, CME-accredited masterclass series; designed to enhance your confidence and decision-making: https://t.co/sZZHcznbDI

[Springer Health+ IME @SpringerIME]

Led by Dr. Vaishali Sanchorawala and Prof. Sebastian Spethmann, our free, interactive case files provide practical insights into building a sustainable MDT amyloidosis care framework, from streamlining care coordination to reducing diagnostic delays: https://t.co/nzTRz8DWqa

[Springer Health+ IME @SpringerIME]

Get ready for #EULAR2026 and explore novel strategies in the management of systemic lupus erythematosus (SLE) with our expert-led video series, now complete with a quick-reference infographic summary to support your clinical decision-making: https://t.co/NHSilCnMAk

[Springer Health+ IME @SpringerIME]

Prof. Carola Dröge and Prof. Verena Keitel-Anselmino speak live from #EASLCongress, discussing IBAT inhibitor therapy in adults with hereditary BSEP-deficiency.

Watch the full video: https://t.co/b43q9UIn4A

[Springer Health+ IME @SpringerIME]

Breaking from #EASLCongress: Observational data show IBAT inhibitor promise for pruritus in late-onset PFIC and ICP.

Read the full story: https://t.co/wSCXDdiji8

[Springer Health+ IME @SpringerIME]

Live from #EASLCongress: Intrahepatic cholestasis of pregnancy recurs in 4 in 10 pregnancies.

Get the full story: https://t.co/Dfh0OQeveG

[Springer Health+ IME @SpringerIME]

Dr Jeremy Nayagam speaks live from #EASLCongress 2026, highlighting research on genetic testing in adults with unexplained cholestatic liver disease and hepatitis.

Watch the full video now, and explore our coverage of the congress: https://t.co/9u1Xs8TZW1

[Springer Health+ IME @SpringerIME]

Live from #EASLCongress: Case series suggests IBAT inhibitor benefits in adults with hereditary BSEP deficiency.

Read the full story: https://t.co/Ey8CRYrd0p

[Springer Health+ IME @SpringerIME]

Breaking from #EASLCongress: Targeted gene sequencing panel resolves unexplained cholestasis in about 5% of adults.

Get the full story: https://t.co/jIBi6MuJxu

[Springer Health+ IME @SpringerIME]

Heading to #ASCO2026? Catch up on the latest therapeutic approaches for mycosis fungoides-type cutaneous T-cell lymphoma in our free, CME-accredited webcast.

Start watching and prepare for meaningful peer-to-peer conversations at ASCO: https://t.co/za6qFsrKdv

[Springer Health+ IME @SpringerIME]

Breaking from #EASLCongress: Genetic variants explain substantial proportion of undiagnosed cholestasis and hepatitis.

Find out more: https://t.co/LpVpVVWKus

[Springer Health+ IME @SpringerIME]

Live from #EASLCongress: Bilirubin and platelet count predict native liver survival in adolescents with ALGS.

Read the full story: https://t.co/8GOPWH1tUc

[Springer Health+ IME @SpringerIME]

Live from #EASLCongress: Researchers call for ICP to be included in hepatobiliary risk stratification.

Read the full story here: https://t.co/uswwzmtTnG

[Springer Health+ IME @SpringerIME]

Navigating neuroimaging in Alzheimer’s care: Put your PET tracer selection and interpretation skills into practice using our Case Challenge series.

Get started for free and strengthen your diagnosis, disease staging, and treatment decision-making: https://t.co/BFr8F1LYFe

[Springer Health+ IME @SpringerIME]

Are you at #EASLCongress in Barcelona? Stop by Booth C04 to find out more about our key IME programs in rare liver disorders.

[Springer Medicine @Springer_Med]

We're here at #EASLCongress in Barcelona!

Stop by Booth C04 to find out more about Springer Medicine, our free medical education platform, as well as our key IME programs in hepatology 🎯

[Springer Health+ IME @SpringerIME]

Looking for key information on the utility of biomarkers, interpretation of biomarkers, and use of biomarkers for treatment selection in an easy-to-use, downloadable format?

Build your own infographic, and tailor the insights to your clinical practice: https://t.co/IOGS580ytn

[Springer Health+ IME @SpringerIME]

In our free, three-part video podcast series, hosted by @Dr_AmerZeidan, hear directly from the experts on genetic testing and diagnostics, emerging targeted therapies, and personalized treatments in relapsed/refractory (R/R) AML: https://t.co/dF49nCaxVK

[Springer Health+ IME @SpringerIME]

Unpick the role of the tumor microenvironment in mycosis fungoides-type cutaneous T-cell lymphoma in our free, CME-accredited webcast, led by Dr. Larisa J. Geskin.

Start watching to sharpen your focus and apply the latest insights to your practice: https://t.co/KKEVofyppZ

[Springer Health+ IME @SpringerIME]

From emerging therapies to tactics for multidisciplinary collaboration, our free, CME-accredited video podcast series led by Dr Kelly Gwathmey combines expert insights with scientific data to help clinicians deliver an optimized gMG care strategy: https://t.co/dSZj6CHeZT

[Springer Health+ IME @SpringerIME]

What were 2025’s most significant breakthroughs in next-generation CAR-T cell therapy for high-risk LBCL and R/R DLBCL? Leading experts discuss in this on-demand webcast, drawing on landmark data from the most recent EHA and ASH meetings. Get the insights: https://t.co/sTT1KcjPx4